Millendo Therapeutics, Inc.
USD1.06
-0.06 (-5.36%)
CEO
Julia Owens
IPO Date
2012-10-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.12
Prev. Close
$1.12
Day Low
$1.06
Day High
$1.13
52W Low
$1.06
52W High
$41.55
Market Cap
$0.01B
Volume
1.91M
| 12,000 |
| $2.40 |
| 23 Jun 2020 | Hindman James M. | director | A-Award | Acquired | 12,000 | $2.40 |
| 23 Jun 2020 | Nuechterlein Carole | director | A-Award | Acquired | 12,000 | $2.40 |
| 23 Jun 2020 | HOWE JOHN P MD | director | A-Award | Acquired | 12,000 | $2.40 |
| 27 May 2020 | Arbet-Engels Christophe | Chief Medical Officer | A-Award | Acquired | 80,000 | $2.00 |
| 27 May 2020 | JOSEPH TAMARA L | General Counsel and Secretary | A-Award | Acquired | 80,000 | $2.00 |
| 11 Feb 2020 | Arbet-Engels Christophe | Chief Medical Officer | A-Award | Acquired | 140,000 | $6.90 |
| 11 Feb 2020 | Arbet-Engels Christophe | officer | Disposed | 0 | $0.00 |
| 4 Feb 2020 | JOSEPH TAMARA L | General Counsel and Secretary | A-Award | Acquired | 56,250 | $7.94 |